Reporting of race and ethnicity in breast cancer research: room for improvement

被引:0
作者
Kelly W. Mitchell
Lisa A. Carey
Jeffrey Peppercorn
机构
[1] University of North Carolina School of Medicine,Department of Medicine
[2] University of North Carolina School of Medicine,Division of Hematology/Oncology
[3] Duke University Medical Center,Division of Medical Oncology
来源
Breast Cancer Research and Treatment | 2009年 / 118卷
关键词
Breast cancer; Health disparities; Clinical trials; Race;
D O I
暂无
中图分类号
学科分类号
摘要
Health disparities in breast cancer outcomes according to race/ethnicity are well documented. Randomized clinical trials (RCT) offer an opportunity to evaluate differences in disease biology and response to therapy that may contribute to disparities. We conducted a PubMed search to identify all English language original reports of breast cancer RCT from October 2001 to October 2006. The primary outcomes of interest were reporting of accrual and results by race or ethnicity of trial subjects. We evaluated the correlation between study characteristics and reporting of race/ethnicity. A total of 197 eligible trials were identified among 29 journals. Accrual was reported by race in 17% of studies and results analyzed by race in only 2%. Reporting of race was associated with National Cancer Institute funding (38 vs. 13%, P = 0.001), US cooperative group trials (52 vs. 13%, P < 0.0001), trials with US sites (43 vs. 5%, P < 0.0001), and trials enrolling > 500 subjects (24 vs. 12%, P = 0.055). Pharmaceutical industry funding, # of centers, stage of disease, nature of experimental intervention and study outcomes were not associated with reporting of race. Among US studies reporting trial accrual by race/ethnicity, the mean accrual distribution was 81% white, 7.6% black, 9.6% Asian, and 7.2% Hispanic subjects. The majority of breast cancer RCT fail to report the race/ethnicity of participants. Low accrual of black subjects and failure to report accrual and outcomes by race in RCT may contribute to difficulty in understanding and overcoming health disparities in breast cancer.
引用
收藏
页码:511 / 517
页数:6
相关论文
共 153 条
[1]  
Curtis E(2008)Racial and ethnic differences in breast cancer survival: how much is explained by screening, tumor severity, biology, treatment, comorbidities, and demographics? Cancer 112 171-180
[2]  
Quale C(1994)Racial differences in survival from breast cancer. Results of the National Cancer Institute Black/White cancer survival study JAMA 272 947-954
[3]  
Haggstrom D(2006)Meta-analysis of survival in African American and white American patients with breast cancer: ethnicity compared with socioeconomic status J Clin Oncol 24 1342-1349
[4]  
Smith-Bindman R(2002)Survival of blacks and whites after a cancer diagnosis JAMA 287 2106-2113
[5]  
Eley JW(2003)Trends in breast cancer by race and ethnicity CA Cancer J Clin 53 342-355
[6]  
Hill HA(2003)Differences in breast cancer stage, treatment, and survival by race and ethnicity Arch Intern Med 163 49-56
[7]  
Chen VW(2006)Missed opportunities: racial disparities in adjuvant breast cancer treatment J Clin Oncol 24 1357-1362
[8]  
Austin DF(2005)Comorbidity and survival disparities among black and white patients with breast cancer JAMA 294 1765-1772
[9]  
Wesley MN(2006)Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study JAMA 295 2492-2502
[10]  
Muss HB(2007)Factors associated with advanced disease stage at diagnosis in a population-based study of patients with newly diagnosed breast cancer Am J Epidemiol 166 1035-1044